STAT

Opinion: Azar is empowering anti-fetal tissue research ideologues at the expense of science

Legally and ethically obtained fetal tissue is an essential component of research. Blocking this kind of research would harm millions of people around the globe.
Source: Alex Wong/Getty Images

Earlier this month, Alex Azar, secretary of the Department of Health and Human Services, visited South America, where he touted the work the United States has done to halt the spread of diseases in the region. Azar, a former pharmaceutical executive, highlighted the importance of vaccines in preventing the spread of diseases like measles and diphtheria.

He was right. The United States has played a leading role in disease prevention research and has funded programs that have undoubtedly saved the lives of millions of people in South

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks